The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 02, 2019

Filed:

Jul. 14, 2017
Applicants:

Xiamen University, Xiamen, CN;

Xiamen Innovax Biotech Co., Ltd., Xiamen, CN;

Inventors:

Quan Yuan, Xiamen, CN;

Tianying Zhang, Xiamen, CN;

Wenxin Luo, Xiamen, CN;

Yixin Chen, Xiamen, CN;

Jun Zhang, Xiamen, CN;

Ningshao Xia, Xiamen, CN;

Assignees:

Xiamen University, Xiamen, Fujian, CN;

Yang Sheng Tang Company, Ltd., Haikou, Hainan, CN;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/005 (2006.01); A61K 39/12 (2006.01); G01N 33/569 (2006.01); C07K 16/08 (2006.01); C07K 7/06 (2006.01); C12P 21/02 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/005 (2013.01); A61K 39/12 (2013.01); C07K 7/06 (2013.01); C07K 16/082 (2013.01); C12P 21/02 (2013.01); G01N 33/56983 (2013.01); A61K 2039/505 (2013.01); A61K 2039/6037 (2013.01); C07K 2317/24 (2013.01); C07K 2317/76 (2013.01); C12N 2730/10122 (2013.01); C12N 2730/10134 (2013.01); G01N 2333/02 (2013.01);
Abstract

The present invention relates to epitope peptides (or mutants thereof) for treating hepatitis B virus infection, recombinant proteins comprising such epitope peptides (or mutants thereof) and carrier proteins, and uses of such epitope peptides (or mutants thereof) and recombinant proteins. The present invention also relates to antibodies against such epitope peptides, cell lines producing said antibodies, and uses thereof. Furthermore, the present invention relates to vaccines or pharmaceutical compositions for treating or alleviating one or more symptoms associated with hepatitis B virus infection, which comprise the recombinant proteins or antibodies according to the invention, respectively.


Find Patent Forward Citations

Loading…